MARCUS MAGNET: Open Payments
NPI 1740249457 · WOODBURY, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,773 in 100 payments from 25 companies in 2025. Trend: 2023 $1,902 · 2024 $1,843 · 2025 $1,773
Food & beverage: $1,773
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $283 |
| AstraZeneca Pharmaceuticals LP | 9 | $220 |
| Novo Nordisk Inc | 14 | $209 |
| Vanda Pharmaceuticals Inc. | 6 | $111 |
| Janssen Pharmaceuticals, Inc | 6 | $104 |
| Exact Sciences Corporation | 4 | $87 |
| Abbott Laboratories | 4 | $81 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $81 |
| Lilly USA, LLC | 4 | $75 |
| Teva Pharmaceuticals USA, Inc. | 4 | $68 |
Products named: VRAYLAR, FANAPT, SPRAVATO, Ozempic, The Cologuard Plus Collection Kit, FARXIGA, UBRELVY, FREESTYLE LIBRE 3.
Industry payments across NJ — which companies pay providers there.
